銀行貸款 小額借貸 線上貸款 汽車貸款 手機貸 瘋正妹 橘子影城 古蹟交流社 東森新聞手機板 東森新聞 港書館 super娛樂城 金鈦城娛樂城 信用版娛樂城 贏家娛樂城 WG娛樂城
| Over the past | Total investment | Would've become | Historic returns | Returns |
|---|---|---|---|---|
| 6 months | ?30,000 | ?32,236 | +7.45% | |
| 1 year | ?60,000 | ?64,378 | +7.30% | |
| 3 years | ?1,80,000 | ?2,26,135 | +25.63% | |
| 5 years | ?3,00,000 | ?4,46,053 | +48.68% |
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 10.61% |
| Divi's Laboratories Ltd | Healthcare | Equity | 7.56% |
| Repo | Unspecified | Repo | 7.29% |
| Apollo Hospitals Enterprise Ltd | Healthcare | Equity | 6.63% |
| Torrent Pharmaceuticals Ltd | Healthcare | Equity | 6.51% |
| Neuland Laboratories Ltd | Healthcare | Equity | 5.49% |
| Navin Fluorine International Ltd | Materials | Equity | 5.38% |
| Aurobindo Pharma Ltd | Healthcare | Equity | 4.98% |
| Fortis Healthcare Ltd | Healthcare | Equity | 4.49% |
| Gland Pharma Ltd | Healthcare | Equity | 3.55% |
| Zydus Lifesciences Ltd | Healthcare | Equity | 3.15% |
| Onesource Specialty Pharma Ltd | Healthcare | Equity | 3.08% |
| Aster DM Healthcare Ltd | Healthcare | Equity | 3.07% |
| Glenmark Pharmaceuticals Ltd | Healthcare | Equity | 3.07% |
| Biocon Ltd | Healthcare | Equity | 3.06% |
| Global Health Ltd | Healthcare | Equity | 2.97% |
| Metropolis Healthcare Ltd | Healthcare | Equity | 2.95% |
| Artemis Medicare Services Ltd | Healthcare | Equity | 2.87% |
| Ipca Laboratories Ltd | Healthcare | Equity | 2.85% |
| Mankind Pharma Ltd. | Healthcare | Equity | 2.29% |
| Ami Organics Ltd | Healthcare | Equity | 2.22% |
| Anthem Biosciences Ltd. | Healthcare | Equity | 2.16% |
| Dr. Agarwal’S Health Care Ltd. | Healthcare | Equity | 2.15% |
| Max Healthcare Institute Ltd | Healthcare | Equity | 1.82% |
| Net Payables | Unspecified | Net Payables | -0.21% |
| Name | 1Y | 3Y | 5Y | All |
|---|---|---|---|---|
| Fund returns | +9.7% | +22.4% | +12.2% | +18.2% |
| Category average (Equity Sectoral) | -2.1% | +22.1% | +14.6% | -- |
| Rank (Equity Sectoral) | 13 | 7 | 7 | -- |